Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans
Not Applicable
Completed
- Conditions
- Bioequivalence Study in Healthy Subjects
- Interventions
- Drug: Budiair® 200ug/puff inhalation aerosolDrug: budesonide 200ug/puff inhalation aerosol
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Lunan Better Pharmaceutical Co., LTD.
- Target Recruit Count
- 32
- Registration Number
- NCT06924190
- Locations
- 🇨🇳
Wuxi People's Hospital, Wuxi, Jiangsu, China
🇨🇳Lunan Better Pharmaceutical Co., Ltd., Linyi, Shandong, China
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
Phase 3
Recruiting
- Conditions
- Dry Eye Disease (DED)
- Interventions
- Drug: Drug placebo
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Lunan Better Pharmaceutical Co., LTD.
- Target Recruit Count
- 820
- Registration Number
- NCT06879782
- Locations
- 🇨🇳
Beijing Tongren Hospital, Capital Medical University, Peking, Beijing, China
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
Phase 2
Not yet recruiting
- Conditions
- Meniere´s Disease
- Interventions
- Drug: Isosorbide oral solutionDrug: Placebo
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Lunan Better Pharmaceutical Co., LTD.
- Target Recruit Count
- 234
- Registration Number
- NCT06765993
© Copyright 2025. All Rights Reserved by MedPath